Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed o6-methylguanine-DNA-methyltransferase (MGMT) Negative Glioblastoma Multiforme (GBM)

Condition:   Glioblastoma Multiforme of Brain Interventions:   Biological: TVI-Brain-1;   Procedure: Standard of Care;   Radiation: Radiotherapy;   Drug: Temozolomide Sponsors:   TVAX Biomedical;   FDA Office of Orphan Products Development Not yet recruiting

Source: ClinicalTrials.gov - January 13, 2023 Category: Research Source Type: clinical trials